Advertisement

Inpharma Weekly

, Volume 1280, Issue 1, pp 14–14 | Cite as

Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC

Clinical study
  • 3 Downloads

Keywords

Lung Cancer Median Survival Docetaxel Cell Lung Cancer Gemcitabine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2001

Personalised recommendations